- Home
- THQ vs BVS Comparison
THQ vs BVS Comparison
Compare THQ & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THQ
- BVS
- Stock Information
- Founded
- THQ 2014
- BVS 2011
- Country
- THQ United States
- BVS United States
- Employees
- THQ N/A
- BVS N/A
- Industry
- THQ Finance Companies
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- THQ Finance
- BVS Health Care
- Exchange
- THQ Nasdaq
- BVS Nasdaq
- Market Cap
- THQ 780.4M
- BVS 698.1M
- IPO Year
- THQ N/A
- BVS 2021
- Fundamental
- Price
- THQ $19.92
- BVS $10.04
- Analyst Decision
- THQ
- BVS Strong Buy
- Analyst Count
- THQ 0
- BVS 3
- Target Price
- THQ N/A
- BVS $15.00
- AVG Volume (30 Days)
- THQ 158.9K
- BVS 345.4K
- Earning Date
- THQ 01-01-0001
- BVS 03-11-2025
- Dividend Yield
- THQ 7.53%
- BVS N/A
- EPS Growth
- THQ N/A
- BVS N/A
- EPS
- THQ N/A
- BVS N/A
- Revenue
- THQ N/A
- BVS $555,061,000.00
- Revenue This Year
- THQ N/A
- BVS $11.37
- Revenue Next Year
- THQ N/A
- BVS $1.04
- P/E Ratio
- THQ N/A
- BVS N/A
- Revenue Growth
- THQ N/A
- BVS 10.40
- 52 Week Low
- THQ $15.29
- BVS $3.90
- 52 Week High
- THQ $20.38
- BVS $14.38
- Technical
- Relative Strength Index (RSI)
- THQ 60.02
- BVS 45.71
- Support Level
- THQ $18.59
- BVS $8.77
- Resistance Level
- THQ $19.14
- BVS $10.90
- Average True Range (ATR)
- THQ 0.29
- BVS 0.50
- MACD
- THQ 0.17
- BVS 0.03
- Stochastic Oscillator
- THQ 89.26
- BVS 57.99
About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
Tekla Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies in the healthcare industry (including equity securities, debt securities, and pooled investment vehicles). The fund invests in securities of public and private companies.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.